Effect of Shenqi Compound Formula on PPARγ in White Adipose Tissue of Rats with Macrovascular Lesion in Early Stage of Diabetes

Objective: To investigate the effect of Shenqi Compound Formula (SCF) on peroxisome proliferators- activated receptor γ (PPARγ) in white adipose tissue of rats with macrovascular lesion in early stage of diabetes. Methods: Corresponding treatment was given to rats in model group, Ramipril group, nor...

Full description

Saved in:
Bibliographic Details
Published inJournal of traditional Chinese medicine Vol. 28; no. 2; pp. 134 - 138
Main Author 张红敏 谢春光 陈世伟 谢毅强 王友京(译)
Format Journal Article
LanguageEnglish
Published West China Hospital of Sichuan University,Chengdu 610041,China%Chengdu University of Traditional Chinese Medicine,China%Food and Drug Administration of Henan,China 01.06.2008
Subjects
Online AccessGet full text
ISSN0255-2922
DOI10.1016/S0254-6272(08)60032-1

Cover

More Information
Summary:Objective: To investigate the effect of Shenqi Compound Formula (SCF) on peroxisome proliferators- activated receptor γ (PPARγ) in white adipose tissue of rats with macrovascular lesion in early stage of diabetes. Methods: Corresponding treatment was given to rats in model group, Ramipril group, normal control group, low dosage SCF group and high dosage SCF group respectively for 32 days. The expressions of PPARγ and adiponectin Messenger RNA (mRNA) were detected by real-time reverse transcriptase poly- merase chain reaction. Results: The expressions of PPARγ and adiponectin mRNA increased significantly in both low and high dosage SCF groups as compared with the model group, and a positive linear correlation was found between the expressions of PPARγ and adiponectin mRNA. Conclusions: SCF can prevent macrovascular lesion in early stage of diabetes, which is possibly related with up-regulating expressions of PPARγ and activating PPARγ.
Bibliography:Peroxisome proliferators-activated receptor γ (PPARγ)
Shenqi Compound Formula; TypeⅡ Diabetes; Macrovascular lesion; Peroxisome proliferators-activated receptor γ (PPARγ)
11-2167/R
R28
TypeⅡ Diabetes
Shenqi Compound Formula
Macrovascular lesion
ISSN:0255-2922
DOI:10.1016/S0254-6272(08)60032-1